Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-transplant lymphoproliferative disease.

Vikas R Dharnidharka1, Carlos E Araya

  • 1Division of Pediatric Nephrology, University of Florida College of Medicine, PO Box 100296, 1600 SW Archer Road, Gainesville, FL 32610-0296, USA. vikasmd@peds.ufl.edu

Pediatric Nephrology (Berlin, Germany)
|September 25, 2007
PubMed
Summary

Post-transplant lymphoproliferative disease (PTLD) is a serious complication after pediatric kidney transplants, often linked to Epstein-Barr virus (EBV). Treatment and prevention strategies lack randomized trials, leaving their effectiveness uncertain.

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Introduction to pediatric solid organ transplantation - not just little adults!

Current opinion in organ transplantation·2026
Same author

Natural History of C3 Glomerulopathy and Immune Complex-Associated Membranoproliferative Glomerulonephritis in Children.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Contemporary Treatment Responses of Recurrent Focal Segmental Glomerulosclerosis or Steroid Resistant Nephrotic Syndrome in Children after Kidney Transplantation: Phase 2 of a Multicenter Electronic Health Record Data Analysis.

Research square·2026
Same author

Comparative Effectiveness of Different Influenza Vaccine Formulations among Patients Undergoing Maintenance Hemodialysis.

Journal of the American Society of Nephrology : JASN·2026
Same author

Uptake of Newly Licensed Influenza Vaccine Formulations Among Patients Receiving Chronic Hemodialysis During the 2010/2011 to 2021/2022 Influenza Seasons.

Kidney medicine·2026
Same author

Challenges in Small Sample Size Cluster Trials for Medication Adherence: Insights From TAKE-IT-TOO.

Pediatric transplantation·2025

Area of Science:

  • Pediatric Nephrology
  • Transplantation Immunology
  • Oncology

Background:

  • Post-transplant lymphoproliferative disease (PTLD) is a significant complication in pediatric kidney transplantation.
  • PTLD involves uncontrolled B lymphocyte proliferation, often associated with Epstein-Barr virus (EBV).
  • Risk factors include younger age, Caucasian race, and potent immunosuppression.

Purpose of the Study:

  • To summarize the current understanding of PTLD in pediatric kidney transplantation.
  • To outline diagnostic and therapeutic approaches.
  • To highlight the challenges in PTLD prevention and treatment efficacy evaluation.

Main Methods:

  • Diagnosis relies primarily on histopathological features.
  • Treatment strategies encompass immunosuppression reduction, anti-B cell antibodies, EBV-specific cytotoxic T lymphocytes, and chemotherapy.

Related Experiment Videos

  • Prevention strategies include EBV viral load monitoring and antiviral prophylaxis.

    • Main Results:

    • Clinical presentation typically involves lymphadenopathy but can vary.
    • PTLD remains a risk factor for graft loss.
    • Re-transplantation has not been associated with repeat PTLD.

    Conclusions:

    • The relative efficacy of PTLD treatment and prevention strategies is largely unknown due to a lack of randomized clinical trials.
    • Further research is needed to establish evidence-based guidelines for PTLD management.
    • PTLD management requires a multidisciplinary approach.